These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30914310)

  • 1. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
    Budnik J; DeNunzio NJ; Singh DP; Milano MT
    Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-small-cell lung cancer after breast cancer: a population-based study of clinicopathologic characteristics and survival outcomes in 3529 women.
    Milano MT; Strawderman RL; Venigalla S; Ng K; Travis LB
    J Thorac Oncol; 2014 Aug; 9(8):1081-90. PubMed ID: 25157761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
    Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.
    Milano MT; Li H; Constine LS; Travis LB
    Cancer; 2011 Dec; 117(24):5538-47. PubMed ID: 21692074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.
    Wang H; Yin Y; Wang R; Huang J; Xue H; Cheng Y; Zhang L; Chen C
    BMC Cancer; 2020 Nov; 20(1):1081. PubMed ID: 33172389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previous head and neck cancers portend poor prognoses in lung cancer patients.
    Jayaprakash V; Cheng C; Reid M; Dexter EU; Nwogu CE; Hicks W; Sullivan M; Demmy TL; Yendamuri S
    Ann Thorac Surg; 2011 Sep; 92(3):1056-60; discussion 1060-1. PubMed ID: 21871300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis.
    Hansen RN; Zhang Y; Seal B; Ryan K; Yong C; Darilay A; Ramsey SD
    BMC Cancer; 2020 Apr; 20(1):276. PubMed ID: 32248816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and risk of second primary lung cancer after cervical cancer: A population-based study.
    Qian C; Liu H; Feng Y; Meng S; Wang D; Nie M; Xu M
    PLoS One; 2020; 15(8):e0231807. PubMed ID: 32756555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
    Jung YS; Lim J; Jung KW; Ryu J; Won YJ
    PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment and survival of second primary early-stage lung cancer, following treatment of head and neck cancer in the Netherlands.
    Louie AV; Damhuis RA; Haasbeek CJ; Warner A; Rodin D; Slotman BJ; Leemans CR; Senan S
    Lung Cancer; 2016 Apr; 94():54-60. PubMed ID: 26973207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second Primary Lung Cancer After Head and Neck Cancer: Implications for Screening Computed Tomography.
    Pagedar NA; Jayawardena A; Charlton ME; Hoffman HT
    Ann Otol Rhinol Laryngol; 2015 Oct; 124(10):765-9. PubMed ID: 25881583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of local thoracic surgery in patients with stage IV non-small-cell lung cancer: A SEER-based analysis.
    Jia J; Guo B; Yang Z; Liu Y; Ga L; Xing G; Zhang S; Jin A; Ma R; Wang J
    Eur J Cancer; 2021 Feb; 144():326-340. PubMed ID: 33388490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced cancer after radiotherapy for non-Hodgkin's lymphoma of the head and neck: a retrospective study.
    Toda K; Shibuya H; Hayashi K; Ayukawa F
    Radiat Oncol; 2009 Jul; 4():21. PubMed ID: 19591686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
    Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
    Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second primary lung cancers following a diagnosis of primary head and neck cancer.
    Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S
    Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
    Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
    Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
    Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY
    Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.
    Wu B; Zhang X; Feng N; Hu Z; Wu J; Zhou W; Wei Y; Zhang W; Wang K
    PLoS One; 2024; 19(4):e0298470. PubMed ID: 38683794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.